{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:35:06Z","timestamp":1787906106434,"version":"build-2784847793"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004320","name":"Philips","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Early extraction for cardiovascular implantable electronic device (CIED) infections has been associated with longer survival, while the impact on healthcare utilization is unknown. The aim is to evaluate the impact of early extraction on healthcare expenditures and utilization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Using 100% Medicare fee-for-service data with Part D from 1\/1\/2006 through 12\/31\/2019, patients with a de novo CIED implant and CIED infection &amp;gt; 12 months after implant were identified to analyse healthcare utilization according to the occurrence and timing of extraction. The CIED infection was defined as (i) a claim for endocarditis or infection of a device implant and (i) documented antibiotic therapy. Among 9594 patients with CIED infection [median age 75 years (25th, 75th; 67, 81), 39.9% women], 7819 (81.5%) patients did not undergo extraction within 30 days, 1277 (13.3%) patients had extraction in &amp;lt;7 days, and 498 (5.2%) patients underwent extraction between 7 and 30 days. Following multivariable adjustment, extraction in less than 7 days (adjusted hazard ratio 0.79, 95% confidence interval 0.72\u20130.85, P &amp;lt; 0.001) of CIED infection was associated with lower all-cause hospitalization in follow-up. Healthcare expenditures in the year following CIED infection were higher among the patients without extraction within 30 days (median $63 425; 25th, 75th $22,853, $120 273) and were lowest among patients who underwent extraction &amp;lt; 7 days after diagnosis of CIED infection (median $36 824; 25th, 75th $12,748, $77 772).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Extraction was associated with lower hospitalization and lower healthcare expenditures in the year following CIED infection management period. Early extraction was associated with optimal healthcare utilization and expenditures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euaf146","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T11:39:13Z","timestamp":1754825953000},"source":"Crossref","is-referenced-by-count":4,"title":["Impact of timing of treatment for cardiac implantable electronic device infections on healthcare utilization and expenditures"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4345-0816","authenticated-orcid":false,"given":"Sean D","family":"Pokorney","sequence":"first","affiliation":[{"name":"Division of Cardiology, Duke University Medical Center , DUMC, Durham 3845, NC 27710, USA"},{"name":"Duke Clinical Research Institute , 300 W Morgan St, Durham, NC 27701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-4866","authenticated-orcid":false,"given":"Lindsay","family":"Zepel","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Duke University School of Medicine , 215 Morris St, Durham, NC 27701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3614-5602","authenticated-orcid":false,"given":"Melissa A","family":"Greiner","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Duke University School of Medicine , 215 Morris St, Durham, NC 27701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Duke University Medical Center , DUMC, Durham 3845, NC 27710, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3929-0177","authenticated-orcid":false,"given":"Donald D","family":"Hegland","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Duke University Medical Center , DUMC, Durham 3845, NC 27710, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0045-3291","authenticated-orcid":false,"given":"Christopher B","family":"Granger","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Duke University Medical Center , DUMC, Durham 3845, NC 27710, USA"},{"name":"Duke Clinical Research Institute , 300 W Morgan St, Durham, NC 27701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5410-0291","authenticated-orcid":false,"given":"Laurence M","family":"Epstein","sequence":"additional","affiliation":[{"name":"Northwell Health , Division of Cardiology, 300 Community Drive, Manhasset, NY 11030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-8689","authenticated-orcid":false,"given":"Roger G","family":"Carrillo","sequence":"additional","affiliation":[{"name":"University of Miami Palmetto General Hospital , Department of Surgery, 2001 W 68th St, Hialeah, FL 33016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-2404","authenticated-orcid":false,"given":"Jonathan P","family":"Piccini","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Duke University Medical Center , DUMC, Durham 3845, NC 27710, USA"},{"name":"Duke Clinical Research Institute , 300 W Morgan St, Durham, NC 27701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2025082906415452300_euaf146-B1","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"2025082906415452300_euaf146-B2","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2012.12.017","article-title":"ACCF\/HRS\/AHA\/ASE\/HFSA\/SCAI\/SCCT\/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance","volume":"61","author":"Russo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025082906415452300_euaf146-B3","first-page":"e382","article-title":"2018 ACC\/AHA\/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation"},{"key":"2025082906415452300_euaf146-B4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.jacep.2017.05.007","article-title":"Complications and health care costs associated with transvenous cardiac pacemakers in a nationwide assessment","volume":"3","author":"Cantillon","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2025082906415452300_euaf146-B5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacep.2019.06.016","article-title":"Trends of cardiovascular implantable electronic device infection in 3 decades: a population-based study","volume":"5","author":"Dai","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"2025082906415452300_euaf146-B6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMcp1107675","article-title":"Clinical practice. Infections of cardiovascular implantable electronic devices","volume":"367","author":"Baddour","year":"2012","journal-title":"N Engl J Med"},{"key":"2025082906415452300_euaf146-B7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2011.04.033","article-title":"16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008","volume":"58","author":"Greenspon","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025082906415452300_euaf146-B8","doi-asserted-by":"crossref","first-page":"e008280","DOI":"10.1161\/CIRCEP.119.008280","article-title":"Impact of cardiac implantable electronic device infection: a clinical and economic analysis of the WRAP-IT trial","volume":"13","author":"Wilkoff","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025082906415452300_euaf146-B9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/13696998.2020.1751649","article-title":"Economic impact of cardiac implantable electronic device infections: cost analysis at one year in a large U.S. health insurer","volume":"23","author":"Eby","year":"2020","journal-title":"J Med Econ"},{"key":"2025082906415452300_euaf146-B10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1378\/chest.124.4.1451","article-title":"Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome","volume":"124","author":"del R\u00edo","year":"2003","journal-title":"Chest"},{"key":"2025082906415452300_euaf146-B11","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.hrthm.2011.05.015","article-title":"Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections","volume":"8","author":"Le","year":"2011","journal-title":"Heart Rhythm"},{"key":"2025082906415452300_euaf146-B12","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1161\/CIR.0000000000001187","article-title":"Update on cardiovascular implantable electronic device infections and their prevention, diagnosis, and management: a scientific statement from the American Heart Association","volume":"149","author":"Baddour","year":"2024","journal-title":"Circulation"},{"key":"2025082906415452300_euaf146-B13","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1016\/j.hrthm.2017.09.001","article-title":"2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction","volume":"14","author":"Kusumoto","year":"2017","journal-title":"Heart Rhythm"},{"key":"2025082906415452300_euaf146-B14","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/eurheartj\/ehaa010","article-title":"European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"41","author":"Blomstr\u00f6m-Lundqvist","year":"2020","journal-title":"Eur Heart J"},{"key":"2025082906415452300_euaf146-B15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.hrthm.2021.12.023","article-title":"Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices","volume":"19","author":"Lee","year":"2022","journal-title":"Heart Rhythm"},{"key":"2025082906415452300_euaf146-B16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med Care"},{"key":"2025082906415452300_euaf146-B17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2025082906415452300_euaf146-B18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","article-title":"Development of a claims-based frailty indicator anchored to a well-established frailty phenotype","volume":"55","author":"Segal","year":"2017","journal-title":"Med Care"},{"key":"2025082906415452300_euaf146-B19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/biomet\/87.2.329","article-title":"Estimating medical expenditures with censored data","volume":"87","author":"Bang","year":"2000","journal-title":"Biometrika"},{"key":"2025082906415452300_euaf146-B20","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archinternmed.2011.441","article-title":"Mortality and cost associated with cardiovascular implantable electronic device infections","volume":"171","author":"Sohail","year":"2011","journal-title":"Arch Intern Med"},{"key":"2025082906415452300_euaf146-B21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jamacardio.2023.3379","article-title":"Lead extraction and mortality among patients with cardiac implanted electronic device infection","volume":"8","author":"Pokorney","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2025082906415452300_euaf146-B22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/17434440.2022.2151360","article-title":"Prognostic value of renal failure inpatients undergoing transvenous lead extraction: single centre experience and systematic review of the literature","volume":"19","author":"Massaro","year":"2022","journal-title":"Expert Rev Med Devices"},{"key":"2025082906415452300_euaf146-B23","doi-asserted-by":"crossref","first-page":"euad325","DOI":"10.1093\/europace\/euad325","article-title":"Lead extraction today: a matter of time or a matter of way?","volume":"25","author":"Diemberger","year":"2023","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/8\/euaf146\/64160295\/euaf146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/8\/euaf146\/64160295\/euaf146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:41:59Z","timestamp":1756464119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euaf146\/8243860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaf146","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,8]]},"article-number":"euaf146"}}